Showing 1311-1320 of 3058 results for "".
Return of Auras Following Treatment of Focal-Onset Seizures with Responsive Neurostimulation
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/return-of-auras-following-treatment-of-focal-onset-seizures-with-responsive-neurostimulation/32017/Closing Care Gaps by Thinking, Talking, and Treating Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/closing-care-gaps-by-thinking-talking-and-treating-migraine/31970/Neurologists can help patients receive proper and timely care.Headache Horizons: Rebound Abounds in Chronic Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-rebound-abounds-in-chronic-migraine/31593/Despite clear definitions in guidelines, many questions remain regarding medication-overuse headaches in the context of chronic migraine.Challenge Case Report: Left-Sided Headache & Dizziness
https://practicalneurology.com/diseases-diagnoses/stroke/challenge-case-report-left-sided-headache-dizziness/31828/A relatively benign presentation with a cannot-miss diagnosis.Headache Horizons: Attack of the TACs!
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-attack-of-the-tacs/31562/Trigeminal autonomic cephalalgias can be vexing—difficult to recognize and hard to treat.Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.Board Re-Certification: Reform or Reboot
https://practicalneurology.com/columns/practice-management/board-re-certification-reform-or-reboot/30542/A neurologist has been leading the charge to reform MOC in neurology. He talked to Practical Neurology® about the issue.Rising Drug Prices and the Cost of Care: What Can Physicians Do?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/rising-drug-prices-and-the-cost-of-care-what-can-physicians-do/30327/The multiple sclerosis drug market offers a snapshot of a growing problem. Physicians should speak out on behalf of the specialty and their patients.Preferred Treatment: The Changing Economics of Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/preferred-treatment-the-changing-economics-of-multiple-sclerosis-care/30486/By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.NeuroAdvocacy: Why Lobbying Matters
https://practicalneurology.com/columns/practice-management/neuroadvocacy-why-lobbying-matters/30328/Advocating for patients and the specialty is a powerful way for physicians to make their voices heard.